Inhibrx

-$0.16 (-0.40%) As of 7:29 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Inhibrx and other ETFs, options, and stocks.

About INBX

Inhibrx, Inc. is a biotechnology company. It is a clinical stage company, which focuses on developing pipeline of novel biologic therapeutic candidates.

CEO
Mark P. Lappe
Employees
91
Headquarters
La Jolla, California
Founded
2010

INBX Key Statistics

Market Cap
1.50B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
374.08K
High Today
$40.45
Low Today
$38.66
Open Price
$39.44
Volume
83.18K
52 Week High
$50.97
52 Week Low
$14.27

INBX Earnings

-$0.77
-$0.51
-$0.26
$0.00
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Estimated
— per share
Actual
Expected Nov 8, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure